MYOD1 and idiopathic pulmonary fibrosis: In addition, senescent/IPF myofibroblasts overexpress the transcription factor MyoD, which acts as a critical switch in the differentiation and dedifferentiation of myofibroblasts, suggesting that MyoD silencing may represent a potential therapeutic strategy in IPF and other fibrotic diseases.